Data Bridge Market Research analyses that the Asia-Pacific syndromic multiplex diagnostic market will grow at a CAGR of 9.6% during the forecast period of 2022 to 2029.
Syndromic multiplex testing is used to diagnose many pathogens simultaneously. In the syndromic multiplex diagnostic, various types of reagents consumables and instruments accessories are used, which helps maintain accuracy and provide fast diagnosis results. These multiplex tests are rapidly diagnosed with certain infections, allowing clinical management decisions to be made promptly. The tests based on multiplex technology are known as test panel. The panels used in syndromic testing are designed to diagnose multiple diseases associated with the same or similar type of syndrome. These panels help evaluate the cause of the disease at the point of care. Gastrointestinal panels and respiratory panels are the types of syndromic panels.
Syndromic multiplex testing utilizes the advanced technology of multiplex PCR which provides accurate and fast diagnostic results, with the help of the multiple panels which is used in syndromic multiplex diagnostic to provide diagnostic results within an hour. The new generations of syndromic multiplex can rapidly identify the common type of pathogens in the respiratory specimens, blood and cerebrospinal. The use of multiplex panels is associated with quicker turnaround time, reduction of other unnecessary laboratory tests, faster diagnosis and targeted treatment.
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-syndromic-multiplex-diagnostic-market
APAC Syndromic Multiplex Diagnostic Market Regional Analysis/Insights
The syndromic multiplex diagnostic market is analyzed, and market size insights and trends are provided by country, product and services, infection type, disease, panels type and end user, as referenced above.
The countries covered in the report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.
Some of the major players operating in the Asia-Pacific syndromic multiplex diagnostic market are BioFire Diagnostics (A Subsidiary of bioMérieux SA), Seegene Inc., Luminex Corporation. A DiaSorin Company, F. Hoffmann-La Roche Ltd, BD, Bio-Rad Laboratories, Inc., Cepheid (A Subsidiary of Danaher), QIAGEN, Abbott, Hologic, Inc., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Biocartis, QuantuMDx Group Ltd., Prominex Inc, Curetis (A Subsidiary of OpGen, Inc.), MiRXES Pte Ltd. among others.
APAC Syndromic Multiplex Diagnostic Market Scope
Product and Services
- Reagents Consumables
- Instruments, Software Accessories
- Services
Based on products and services, the Asia-Pacific syndromic multiplex diagnostic market is segmented into reagents consumables, instruments, software accessories and services.
Infection Type
- Viral
- Bacterial
- Parasites
- Fungal
Based on infection type, the Asia-Pacific syndromic multiplex diagnostic market is segmented into viral, bacterial, parasites and fungal
Disease
- Respiratory Infection
- Gastroneteritis
- Sexually Transmitted Infections
- Sepsis
- Meningitis
- Others
Based on disease, the Asia-Pacific syndromic multiplex diagnostic market is segmented into respiratory infections, gastroenteritis, sexually transmitted infections, sepsis meningitis and others
Panels Type
- Respiratory Panel
- GI-Enteric Panel
- Sexually Transmitted Disease Panel
- Blood-Sepsis Panel
- Meningitis Panel
- Others
Based on panels type, the Asia-Pacific syndromic multiplex diagnostic market is segmented into respiratory panel, GI-enteric panel, sexually transmitted disease panel, blood-sepsis panel, meningitis panel and others
End User
- Hospitals
- Clinical Laboratories
- Pharmaceutical Biotechnology Companies
- Research Institutes
- Others
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-syndromic-multiplex-diagnostic-market
https://www.databridgemarketresearch.com/reports/europe-syndromic-multiplex-diagnostic-market
https://www.databridgemarketresearch.com/reports/north-america-syndromic-multiplex-diagnostic-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
